<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Nonarteritic anterior ischemic optic neuropathy: Clinical features and diagnosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Nonarteritic anterior ischemic optic neuropathy: Clinical features and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Nonarteritic anterior ischemic optic neuropathy: Clinical features and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Madhura Tamhankar, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nicholas J Volpe, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul W Brazis, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Janet L Wilterdink, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Feb 11, 2020.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Ischemic optic neuropathy is the most common optic nerve disorder in patients over age 50 years. A recent population-based study from Korea found an incidence of 11.3 amongst 100,000 individuals of nonarteritic anterior ischemic optic neuropathy (NAION) [<a href="#rid1">1</a>]. Ischemic optic neuropathy is generally categorized as anterior (affecting the optic disc) versus posterior (retrobulbar) and as arteritic versus nonarteritic. Anterior involvement is common with both arteritic and nonarteritic ischemic optic neuropathy.</p><p>NAION is the most common form of ischemic optic neuropathy. It is an idiopathic, ischemic insult of the optic nerve head characterized by acute, monocular, painless visual loss with optic disc swelling.</p><p>This topic will discuss the clinical features and diagnosis of NAION. The epidemiology, pathogenesis, etiologies, prognosis, and treatment of NAION are discussed separately. Other forms of ischemic optic neuropathy and other optic neuropathies are discussed separately. (See  <a class="medical medical_review" href="/d/html/5233.html" rel="external">"Nonarteritic anterior ischemic optic neuropathy: Epidemiology, pathogenesis, and etiologies"</a> and  <a class="medical medical_review" href="/d/html/5234.html" rel="external">"Nonarteritic anterior ischemic optic neuropathy: Prognosis and treatment"</a> and  <a class="medical medical_review" href="/d/html/8225.html" rel="external">"Clinical manifestations of giant cell arteritis"</a> and  <a class="medical medical_review" href="/d/html/5244.html" rel="external">"Optic neuropathies"</a>.)</p><p class="headingAnchor" id="H733857992"><span class="h1">CLINICAL FEATURES</span></p><p class="headingAnchor" id="H2"><span class="h2">Presenting symptoms</span><span class="headingEndMark"> — </span>Patients describe monocular loss of vision occurring over hours to days. Symptoms were present upon awakening in as many as 73 percent of patients according to some reports; however, in the Ischemic Optic Neuropathy Decompression Trial (IONDT), symptoms first present on awakening were reported in just 42 percent [<a href="#rid2">2,3</a>]. Some patients report altitudinal (often inferior) vision loss or a scotoma. It is common for visual loss to progress over the first few days; in one study the average time to peak vision loss was approximately five days [<a href="#rid4">4</a>]. Most patients stabilize in one to two weeks [<a href="#rid2">2,5</a>].</p><p>It is rare for the symptoms to occur in both eyes at the same time. In one series, 11 percent had a bilateral presentation, but most of these cases occurred in the setting of severe blood pressure fluctuations (eg, surgery, dialysis) [<a href="#rid6">6</a>]. (See  <a class="medical medical_review" href="/d/html/5233.html" rel="external">"Nonarteritic anterior ischemic optic neuropathy: Epidemiology, pathogenesis, and etiologies", section on 'Etiology and risk factors'</a>.)</p><p>Prodromal ocular or systemic symptoms are atypical for NAION and suggest an alternative etiology such as giant cell arteritis. However, in the IONDT, 5 percent reported that their symptoms were intermittent at onset [<a href="#rid2">2</a>].</p><p>Pain is not typical, but some ocular discomfort has been reported in 8 to 12 percent of individuals [<a href="#rid2">2,4,7</a>]. If pain is a prominent complaint, NAION is less likely to be the diagnosis than optic neuritis or giant cell arteritis (arteritic ischemic optic neuropathy).</p><p class="headingAnchor" id="H3"><span class="h2">Examination findings</span><span class="headingEndMark"> — </span>Examination of patients with NAION typically reveals:</p><p class="bulletIndent1"><span class="glyph">●</span>Reduced visual acuity</p><p class="bulletIndent1"><span class="glyph">●</span>Dyschromatopsia (diminished color vision)</p><p class="bulletIndent1"><span class="glyph">●</span>Afferent pupillary defect</p><p class="bulletIndent1"><span class="glyph">●</span>Optic disc edema (<a class="graphic graphic_picture graphicRef58158" href="/d/graphic/58158.html" rel="external">picture 1</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Peripapillary splinter hemorrhage </p><p class="bulletIndent1"><span class="glyph">●</span>Small optic cup, nerve fiber crowding in the unaffected eye (<a class="graphic graphic_picture graphicRef64959" href="/d/graphic/64959.html" rel="external">picture 2</a>)</p><p></p><p>An entity of so-called incipient NAION has been described in patients who are found on examination to have unilateral optic disc edema [<a href="#rid8">8-10</a>]. Such patients are typically seen in follow-up after a previous episode of NAION in the other eye or for unrelated conditions (eg, diabetic retinopathy). In one series, 25 percent of such patients progressed to symptomatic NAION over a few to several weeks, and a subsequent episode of NAION in that eye occurred in an additional 20 percent [<a href="#rid8">8</a>]. <a class="drug drug_general" data-topicid="8461" href="/d/drug information/8461.html" rel="external">Fluorescein</a> angiography has confirmed filling defects consistent with impaired perfusion in a patient with presymptomatic phase of NAION [<a href="#rid11">11</a>].</p><p>A relative afferent pupillary defect is an invariable manifestation of NAION, as with other optic neuropathies. However, the finding may be subtle if the injury is not severe or if there was previous NAION in the other eye [<a href="#rid12">12</a>].</p><p class="headingAnchor" id="H4"><span class="h3">Optic disc appearance</span><span class="headingEndMark"> — </span>In contrast to giant cell arteritis, the optic disc edema in NAION tends to be hyperemic (<a class="graphic graphic_picture graphicRef58158" href="/d/graphic/58158.html" rel="external">picture 1</a>) rather than pallid (<a class="graphic graphic_picture graphicRef69437" href="/d/graphic/69437.html" rel="external">picture 3</a>). In the IONDT, optic nerve head swelling was diffuse in 75 percent and segmental in 25 percent of patients [<a href="#rid2">2</a>]. Segmental disc edema usually involves the superior portion of the disc; this anatomic distribution has been attributed to the anatomic division of the circle of Zinn-Haller (see  <a class="medical medical_review" href="/d/html/5233.html" rel="external">"Nonarteritic anterior ischemic optic neuropathy: Epidemiology, pathogenesis, and etiologies", section on 'Vascular anatomy'</a>). Segmental disc edema may not correspond to distribution of vision loss.</p><p>Disc hyperemia with peripapillary splinter or flame hemorrhages and dilated telangiectatic capillaries is common and was seen in 72 percent of patients in IONDT (<a class="graphic graphic_picture graphicRef87208" href="/d/graphic/87208.html" rel="external">picture 4</a>) [<a href="#rid2">2</a>]. These features may represent microvascular shunting from ischemic to nonischemic regions of the optic nerve head. The retinal arterioles are typically narrowed focally in the peripapillary region in up to 68 percent of affected patients [<a href="#rid13">13</a>].</p><p>The fellow eye will often reveal a crowded optic nerve head with small or absent physiologic cup (<a class="graphic graphic_picture graphicRef64959" href="/d/graphic/64959.html" rel="external">picture 2</a>) [<a href="#rid14">14-17</a>]. This disk appearance has been denoted the "disk at risk" (see  <a class="medical medical_review" href="/d/html/5233.html" rel="external">"Nonarteritic anterior ischemic optic neuropathy: Epidemiology, pathogenesis, and etiologies", section on 'Ocular risk factors'</a>). In one case series, this finding was noted in 82 percent of cases [<a href="#rid6">6</a>]. Alternatively, the fellow eye may demonstrate optic disc pallor that suggests a prior episode of NAION; in the IONDT, 94 of 420 patients (23 percent) had this finding; 61 of these patients reported a known history of NAION in that eye [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H5"><span class="h3">Vision loss</span><span class="headingEndMark"> — </span>Visual acuity loss in NAION is on average less severe than in arteritic ischemic optic neuropathy, but can range from 20/20 to no light perception. Visual acuity is better than 20/60 in 31 to 52 percent of patients, and is better than 20/200 in one-half to two-thirds of patients [<a href="#rid2">2,4,5,12,18,19</a>]. Some patients with NAION may have normal visual acuity (20/20 or better) [<a href="#rid20">20</a>].</p><p>Color vision is diminished in almost all patients in the affected eye. The color vision loss seems to correlate with the degree of vision loss. By contrast, patients with optic neuritis may have profound color vision loss with relatively good visual recovery.</p><p>An inferior altitudinal visual field defect is the classically described field defect seen in NAION, but among reported case series, its prevalence varies from 25 to 79 percent [<a href="#rid18">18,21,22</a>]. In one series of perimetry studies in 312 eyes, a variety of visual field defects were observed, with an absolute inferior altitudinal defect observed in only 8 percent [<a href="#rid21">21</a>]. The single most commonly observed defect was an inferior nasal defect, found in 22 percent. Other common defects included central, centrocecal, and arcuate scotomas, as well as generalized depression.</p><p class="headingAnchor" id="H6"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>NAION must be differentiated from other entities such as idiopathic, demyelinating, other inflammatory, compressive, and infiltrative optic neuropathies; most of these entities can be differentiated from NAION based on history and ophthalmoscopic disc appearance. </p><p>The major diagnostic consideration is giant cell arteritis or arteritic anterior ischemic optic neuropathy. This also primarily affects older adults, usually over the age of 70 years, and the clinical presentation can be similar. One distinguishing feature of giant cell arteritis is a prodrome of systemic symptoms known as polymyalgia rheumatica, which include jaw claudication, proximal myalgias and arthralgias, scalp tenderness, headache, and fatigue. Disc edema tends to be pallid rather than hyperemic (<a class="graphic graphic_picture graphicRef58158" href="/d/graphic/58158.html" rel="external">picture 1</a> and <a class="graphic graphic_picture graphicRef69437" href="/d/graphic/69437.html" rel="external">picture 3</a>), and transient prodromal vision loss is more common in giant cell arteritis than in NAION. The diagnosis of giant cell arteritis typically requires a temporal artery biopsy. (See  <a class="medical medical_review" href="/d/html/8225.html" rel="external">"Clinical manifestations of giant cell arteritis"</a>.)</p><p>Optic neuritis can also present with acute monocular vision loss with disc edema. In comparison with NAION, patients tend to be younger (usually 18 to 40 years) and pain is usually a prominent feature.</p><p>There are numerous other causes of optic nerve disease (<a class="graphic graphic_table graphicRef75945" href="/d/graphic/75945.html" rel="external">table 1</a>). Some of the clinical features of the more common disorders are contrasted in the table (<a class="graphic graphic_table graphicRef51786" href="/d/graphic/51786.html" rel="external">table 2</a>); these are discussed in more detail separately. (See  <a class="medical medical_review" href="/d/html/5244.html" rel="external">"Optic neuropathies"</a>.)</p><p class="headingAnchor" id="H7"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of NAION in the majority of patients is clinical, based upon age, presence of vasculopathic risk factors, the pattern of visual loss, and the appearance of the swollen disc. A medical history of conditions associated with NAION, (eg, obstructive sleep apnea, use of erectile dysfunction drugs) should be sought. (See  <a class="medical medical_review" href="/d/html/5233.html" rel="external">"Nonarteritic anterior ischemic optic neuropathy: Epidemiology, pathogenesis, and etiologies"</a>.)</p><p>Arteritic (eg, giant cell arteritis) ischemic optic neuropathy should be considered and ruled out. Older adult patients with anterior ischemic optic neuropathy should be questioned regarding headache, scalp tenderness, and jaw claudication for giant cell arteritis. In patients older than 55 years, an erythrocyte sedimentation rate (ESR) and C-reactive protein levels are obtained. Temporal artery biopsy should be considered if these are abnormal or if there is a high clinical suspicion for giant cell arteritis because of suggestive symptoms such as headache or jaw claudication (<a class="graphic graphic_table graphicRef51786" href="/d/graphic/51786.html" rel="external">table 2</a>). (See  <a class="medical medical_review" href="/d/html/8242.html" rel="external">"Diagnosis of giant cell arteritis"</a>.)</p><p>Otherwise, no other testing is required for patients with typical features of NAION. The following features are atypical and suggest the need for further testing [<a href="#rid23">23</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Age less than 50 years</p><p class="bulletIndent1"><span class="glyph">●</span>Absence of vasculopathic risk factors</p><p class="bulletIndent1"><span class="glyph">●</span>Large cup-to-disc ratio in the unaffected eye</p><p class="bulletIndent1"><span class="glyph">●</span>Hemianopic visual field loss</p><p class="bulletIndent1"><span class="glyph">●</span>Bilateral simultaneous or rapidly sequential anterior ischemic optic neuropathy</p><p class="bulletIndent1"><span class="glyph">●</span>Transient visual loss preceding visual loss</p><p class="bulletIndent1"><span class="glyph">●</span>No optic disc edema in acute phase</p><p class="bulletIndent1"><span class="glyph">●</span>Progression after two to four weeks</p><p class="bulletIndent1"><span class="glyph">●</span>Recurrence in same eye</p><p class="bulletIndent1"><span class="glyph">●</span>Inflammation in anterior or posterior segment</p><p class="bulletIndent1"><span class="glyph">●</span>Optic atrophy at presentation</p><p></p><p>If atypical features exist, neuroimaging should be performed to rule out other orbital or intracranial causes. In particular, contrast-enhanced magnetic resonance imaging (MRI) may be useful in younger patients to differentiate NAION and optic neuritis [<a href="#rid12">12,24,25</a>]. While 95 percent of patients with optic neuritis will demonstrate gadolinium contrast enhancement of the optic nerve, this is relatively unusual (&lt;10 percent) in NAION. MRI is also useful to evaluate for compressive and infiltrative optic neuropathies. (See  <a class="medical medical_review" href="/d/html/5244.html" rel="external">"Optic neuropathies"</a>.)</p><p class="headingAnchor" id="H1664759434"><span class="h1">ADDITIONAL EVALUATION</span><span class="headingEndMark"> — </span>Further evaluation in patients with NAION focuses on identifying potential underlying causes and risks factors, particularly those that are modifiable (<a class="graphic graphic_table graphicRef50757" href="/d/graphic/50757.html" rel="external">table 3</a>). (See  <a class="medical medical_review" href="/d/html/5233.html" rel="external">"Nonarteritic anterior ischemic optic neuropathy: Epidemiology, pathogenesis, and etiologies", section on 'Etiology and risk factors'</a>.)</p><p>Generally, carotid Doppler studies and cardiac echocardiography are not indicated for NAION, since embolism is not causative in the vast majority of cases [<a href="#rid26">26</a>]. Magnetic resonance imaging (MRI) and magnetic resonance angiography of the cervical carotid artery may be considered to rule out carotid dissection if there is neck pain, antecedent trauma, or other suggestive features of this diagnosis. (See  <a class="medical medical_review" href="/d/html/5233.html" rel="external">"Nonarteritic anterior ischemic optic neuropathy: Epidemiology, pathogenesis, and etiologies", section on 'Pathogenesis'</a>.)</p><p><a class="drug drug_general" data-topicid="8461" href="/d/drug information/8461.html" rel="external">Fluorescein</a> angiography often reveals delayed filling of the prelaminar layers of the edematous optic disc in acute NAION [<a href="#rid27">27,28</a>]. Poor or absent filling of the choroid is not typical of NAION and suggests giant cell arteritis [<a href="#rid28">28</a>].</p><p>In acute stages of NAION, optical coherence tomography (OCT) will show thickness of the inner and outer layers of the peripapillary retina, while in chronic cases, atrophy of the ganglion cell layer and its axons is seen as inner retinal thinning [<a href="#rid29">29</a>]. OCT angiography (OCT-A) has shown a decreased circum papillary vessel density in acute and old NAION cases [<a href="#rid30">30-34</a>]. The blood flow impairment seen on OCT-A corresponds to structural OCT deficits of the retinal nerve fiber layer (RNFL) and ganglion cell layer complex (GCC), as well as to automated visual field deficits in 90 percent of eyes in one study [<a href="#rid30">30</a>]. Another observational study of 10 patients, however, did not find any correlation of radial capillary network changes to visual field defects [<a href="#rid35">35</a>].</p><p>Measurement of 24-hour blood pressure may identify individuals with nocturnal hypotension (believed to be a risk factor for NAION), but limited treatment options are available for patients at risk [<a href="#rid36">36</a>]. (See  <a class="medical medical_review" href="/d/html/5233.html" rel="external">"Nonarteritic anterior ischemic optic neuropathy: Epidemiology, pathogenesis, and etiologies", section on 'Nocturnal hypotension'</a>.)</p><p>Hypercoagulable studies are generally recommended only if there is a past medical or family history suggesting a thrombogenic tendency, but they should also be considered in young patients (&lt;55 years) without vascular risk factors [<a href="#rid6">6,37-40</a>]. (See  <a class="medical medical_review" href="/d/html/5233.html" rel="external">"Nonarteritic anterior ischemic optic neuropathy: Epidemiology, pathogenesis, and etiologies", section on 'Prothrombotic risk factors'</a>.)</p><p>We typically order polysomnography to evaluate for sleep apnea in patients with NAION who endorse symptoms of daytime sleepiness, have nighttime snoring, and/or are obese. Some studies suggest an association between NAION and obstructive sleep apnea. (See  <a class="medical medical_review" href="/d/html/5233.html" rel="external">"Nonarteritic anterior ischemic optic neuropathy: Epidemiology, pathogenesis, and etiologies", section on 'Sleep apnea syndrome'</a>.)</p><p>Orbital ultrasound may identify optic disc drusen in patients without other risk factors for ischemic optic neuropathy. (See  <a class="medical medical_review" href="/d/html/5233.html" rel="external">"Nonarteritic anterior ischemic optic neuropathy: Epidemiology, pathogenesis, and etiologies", section on 'Ocular risk factors'</a>.)</p><p class="headingAnchor" id="H8"><span class="h1">SUMMARY AND RECOMMENDATIONS</span><span class="headingEndMark"> — </span>Nonarteritic anterior ischemic optic neuropathy (NAION) is the most common cause of optic neuropathy in older adults.</p><p class="bulletIndent1"><span class="glyph">●</span>The typical presentation is sudden onset of painless monocular vision loss, often upon awakening. (See <a class="local">'Presenting symptoms'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Examination findings include optic disc edema, reduced visual acuity (which is often mildly better than 20/60), and an afferent pupillary defect. (See <a class="local">'Examination findings'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A small optic cup is usually seen in the fellow eye and has been termed the "disc at risk." (See <a class="local">'Optic disc appearance'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In individuals older than 70 years, the major alternative diagnostic consideration is giant cell arteritis. Unlike NAION, arteritic ischemic optic neuropathy usually occurs in the setting of polymyalgia rheumatica. All patients over 70 years with ischemic optic neuropathy should have screening blood tests for giant cell arteritis, and further testing if these are abnormal or if the clinical setting is suspicious. (See <a class="local">'Differential diagnosis'</a> above and <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In an older individual (&gt;50 years) with typical clinical features of NAION, further testing beyond screening blood tests for giant cell arteritis is not required. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In young patients (&lt;50 years), optic neuritis should be considered as an alternate diagnosis. Contrast-enhanced brain magnetic resonance imaging (MRI) study demonstrates optic nerve enhancement in most cases of optic neuritis, but very few patients with NAION. (See <a class="local">'Differential diagnosis'</a> above and <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with other atypical features of NAION should also undergo further testing. (See <a class="local">'Diagnosis'</a> above and  <a class="medical medical_review" href="/d/html/5244.html" rel="external">"Optic neuropathies"</a>.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Lee JY, Park KA, Oh SY. Prevalence and incidence of non-arteritic anterior ischaemic optic neuropathy in South Korea: a nationwide population-based study. Br J Ophthalmol 2018; 102:936.</a></li><li><a class="nounderline abstract_t">Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol 1996; 114:1366.</a></li><li><a class="nounderline abstract_t">Hayreh SS, Podhajsky PA, Zimmerman B. Nonarteritic anterior ischemic optic neuropathy: time of onset of visual loss. Am J Ophthalmol 1997; 124:641.</a></li><li><a class="nounderline abstract_t">Rizzo JF 3rd, Lessell S. Optic neuritis and ischemic optic neuropathy. Overlapping clinical profiles. Arch Ophthalmol 1991; 109:1668.</a></li><li><a class="nounderline abstract_t">Boghen DR, Glaser JS. Ischaemic optic neuropathy. The clinical profile and history. Brain 1975; 98:689.</a></li><li><a class="nounderline abstract_t">Preechawat P, Bruce BB, Newman NJ, Biousse V. Anterior ischemic optic neuropathy in patients younger than 50 years. Am J Ophthalmol 2007; 144:953.</a></li><li><a class="nounderline abstract_t">Swartz NG, Beck RW, Savino PJ, et al. Pain in anterior ischemic optic neuropathy. J Neuroophthalmol 1995; 15:9.</a></li><li><a class="nounderline abstract_t">Hayreh SS, Zimmerman MB. Incipient nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2007; 114:1763.</a></li><li><a class="nounderline abstract_t">Prenner JL, Sharma A, Ibarra MS, et al. Prolonged premonitory optic disc signs in anterior ischemic optic neuropathy. J Neuroophthalmol 2002; 22:110.</a></li><li><a class="nounderline abstract_t">Subramanian PS, Gordon LK, Bonelli L, Arnold AC. Progression of asymptomatic optic disc swelling to non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol 2017; 101:671.</a></li><li><a class="nounderline abstract_t">Arnold AC, Costa RM, Dumitrascu OM. The spectrum of optic disc ischemia in patients younger than 50 years (an Amercian Ophthalmological Society thesis). Trans Am Ophthalmol Soc 2013; 111:93.</a></li><li><a class="nounderline abstract_t">Rucker JC, Biousse V, Newman NJ. Ischemic optic neuropathies. Curr Opin Neurol 2004; 17:27.</a></li><li><a class="nounderline abstract_t">Rader J, Feuer WJ, Anderson DR. Peripapillary vasoconstriction in the glaucomas and the anterior ischemic optic neuropathies. Am J Ophthalmol 1994; 117:72.</a></li><li><a class="nounderline abstract_t">Hayreh SS. Anterior ischemic optic neuropathy. Arch Neurol 1981; 38:675.</a></li><li><a class="nounderline abstract_t">Feit RH, Tomsak RL, Ellenberger C Jr. Structural factors in the pathogenesis of ischemic optic neuropathy. Am J Ophthalmol 1984; 98:105.</a></li><li><a class="nounderline abstract_t">Beck RW, Savino PJ, Repka MX, et al. Optic disc structure in anterior ischemic optic neuropathy. Ophthalmology 1984; 91:1334.</a></li><li><a class="nounderline abstract_t">Doro S, Lessell S. Cup-disc ratio and ischemic optic neuropathy. Arch Ophthalmol 1985; 103:1143.</a></li><li><a class="nounderline abstract_t">Repka MX, Savino PJ, Schatz NJ, Sergott RC. Clinical profile and long-term implications of anterior ischemic optic neuropathy. Am J Ophthalmol 1983; 96:478.</a></li><li><a class="nounderline abstract_t">Hayreh SS, Zimmerman MB. Optic disc edema in non-arteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol 2007; 245:1107.</a></li><li><a class="nounderline abstract_t">Hayreh SS, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome. Ophthalmology 2008; 115:298.</a></li><li><a class="nounderline abstract_t">Hayreh SS, Zimmerman B. Visual field abnormalities in nonarteritic anterior ischemic optic neuropathy: their pattern and prevalence at initial examination. Arch Ophthalmol 2005; 123:1554.</a></li><li><a class="nounderline abstract_t">Hattenhauer MG, Leavitt JA, Hodge DO, et al. Incidence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1997; 123:103.</a></li><li><a class="nounderline abstract_t">Lee AG, Lin DJ, Kaufman M, et al. Atypical features prompting neuroimaging in acute optic neuropathy in adults. Can J Ophthalmol 2000; 35:325.</a></li><li><a class="nounderline abstract_t">Rizzo JF 3rd, Andreoli CM, Rabinov JD. Use of magnetic resonance imaging to differentiate optic neuritis and nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2002; 109:1679.</a></li><li><a class="nounderline abstract_t">Gass A, Moseley IF. The contribution of magnetic resonance imaging in the differential diagnosis of optic nerve damage. J Neurol Sci 2000; 172 Suppl 1:S17.</a></li><li><a class="nounderline abstract_t">Fry CL, Carter JE, Kanter MC, et al. Anterior ischemic optic neuropathy is not associated with carotid artery atherosclerosis. Stroke 1993; 24:539.</a></li><li><a class="nounderline abstract_t">Arnold AC, Hepler RS. Natural history of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol 1994; 14:66.</a></li><li><a class="nounderline abstract_t">Arnold AC, Hepler RS. Fluorescein angiography in acute nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1994; 117:222.</a></li><li><a class="nounderline abstract_t">Ackermann P, Brachert M, Albrecht P, et al. Alterations of the outer retina in non-arteritic anterior ischaemic optic neuropathy detected using spectral-domain optical coherence tomography. Clin Exp Ophthalmol 2017; 45:496.</a></li><li><a class="nounderline abstract_t">Ling JW, Yin X, Lu QY, et al. Optical coherence tomography angiography of optic disc perfusion in non-arteritic anterior ischemic optic neuropathy. Int J Ophthalmol 2017; 10:1402.</a></li><li><a class="nounderline abstract_t">Liu CH, Wu WC, Sun MH, et al. Comparison of the Retinal Microvascular Density Between Open Angle Glaucoma and Nonarteritic Anterior Ischemic Optic Neuropathy. Invest Ophthalmol Vis Sci 2017; 58:3350.</a></li><li><a class="nounderline abstract_t">Liu CH, Kao LY, Sun MH, et al. Retinal Vessel Density in Optical Coherence Tomography Angiography in Optic Atrophy after Nonarteritic Anterior Ischemic Optic Neuropathy. J Ophthalmol 2017; 2017:9632647.</a></li><li><a class="nounderline abstract_t">Wright Mayes E, Cole ED, Dang S, et al. Optical Coherence Tomography Angiography in Nonarteritic Anterior Ischemic Optic Neuropathy. J Neuroophthalmol 2017; 37:358.</a></li><li><a class="nounderline abstract_t">Hata M, Oishi A, Muraoka Y, et al. Structural and Functional Analyses in Nonarteritic Anterior Ischemic Optic Neuropathy: Optical Coherence Tomography Angiography Study. J Neuroophthalmol 2017; 37:140.</a></li><li><a class="nounderline abstract_t">Rougier MB, Delyfer MN, Korobelnik JF. OCT angiography of acute non-arteritic anterior ischemic optic neuropathy. J Fr Ophtalmol 2017; 40:102.</a></li><li><a class="nounderline abstract_t">Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 1994; 117:603.</a></li><li><a class="nounderline abstract_t">Salomon O, Huna-Baron R, Kurtz S, et al. Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology 1999; 106:739.</a></li><li><a class="nounderline abstract_t">Feldon SE. Anterior ischemic optic neuropathy: trouble waiting to happen. Ophthalmology 1999; 106:651.</a></li><li><a class="nounderline abstract_t">Biousse V. Coagulation abnormalities and their neuro-ophthalmologic manifestations. Curr Opin Ophthalmol 1999; 10:382.</a></li><li><a class="nounderline abstract_t">Kuhli-Hattenbach C, Scharrer I, Lüchtenberg M, Hattenbach LO. Selective thrombophilia screening of patients with nonarteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol 2009; 247:485.</a></li></ol></div><div id="topicVersionRevision">Topic 5256 Version 11.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28972024" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Prevalence and incidence of non-arteritic anterior ischaemic optic neuropathy in South Korea: a nationwide population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8906027" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9372718" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Nonarteritic anterior ischemic optic neuropathy: time of onset of visual loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1841572" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Optic neuritis and ischemic optic neuropathy. Overlapping clinical profiles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1218373" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Ischaemic optic neuropathy. The clinical profile and history.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17854756" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Anterior ischemic optic neuropathy in patients younger than 50 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7780575" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Pain in anterior ischemic optic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17391767" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Incipient nonarteritic anterior ischemic optic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12131471" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Prolonged premonitory optic disc signs in anterior ischemic optic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27565987" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Progression of asymptomatic optic disc swelling to non-arteritic anterior ischaemic optic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24167327" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The spectrum of optic disc ischemia in patients younger than 50 years (an Amercian Ophthalmological Society thesis).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15090874" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Ischemic optic neuropathies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8291596" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Peripapillary vasoconstriction in the glaucomas and the anterior ischemic optic neuropathies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7305693" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Anterior ischemic optic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6742066" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Structural factors in the pathogenesis of ischemic optic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6514298" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Optic disc structure in anterior ischemic optic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4026643" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Cup-disc ratio and ischemic optic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6624829" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Clinical profile and long-term implications of anterior ischemic optic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17219123" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Optic disc edema in non-arteritic anterior ischemic optic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17698200" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16286618" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Visual field abnormalities in nonarteritic anterior ischemic optic neuropathy: their pattern and prevalence at initial examination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9186104" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Incidence of nonarteritic anterior ischemic optic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11091914" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Atypical features prompting neuroimaging in acute optic neuropathy in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12208717" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Use of magnetic resonance imaging to differentiate optic neuritis and nonarteritic anterior ischemic optic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10606800" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The contribution of magnetic resonance imaging in the differential diagnosis of optic nerve damage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8465359" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Anterior ischemic optic neuropathy is not associated with carotid artery atherosclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7951929" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Natural history of nonarteritic anterior ischemic optic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8116751" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Fluorescein angiography in acute nonarteritic anterior ischemic optic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28133888" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Alterations of the outer retina in non-arteritic anterior ischaemic optic neuropathy detected using spectral-domain optical coherence tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28944200" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Optical coherence tomography angiography of optic disc perfusion in non-arteritic anterior ischemic optic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28687846" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Comparison of the Retinal Microvascular Density Between Open Angle Glaucoma and Nonarteritic Anterior Ischemic Optic Neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28316838" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Retinal Vessel Density in Optical Coherence Tomography Angiography in Optic Atrophy after Nonarteritic Anterior Ischemic Optic Neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28301863" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Optical Coherence Tomography Angiography in Nonarteritic Anterior Ischemic Optic Neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27984351" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Structural and Functional Analyses in Nonarteritic Anterior Ischemic Optic Neuropathy: Optical Coherence Tomography Angiography Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28117076" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : OCT angiography of acute non-arteritic anterior ischemic optic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8172267" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10201595" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10201582" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Anterior ischemic optic neuropathy: trouble waiting to happen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10662242" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Coagulation abnormalities and their neuro-ophthalmologic manifestations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19002482" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Selective thrombophilia screening of patients with nonarteritic anterior ischemic optic neuropathy.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
